NCT06741319 Behavioral and Psychosocial Characteristics of Clients Accessing Services at IHRI
| NCT ID | NCT06741319 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute of HIV Research and Innovation Foundation, Thailand |
| Condition | HIV |
| Study Type | OBSERVATIONAL |
| Enrollment | 300,000 participants |
| Start Date | 2013-07-02 |
| Primary Completion | 2030-07-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300,000 participants in total. It began in 2013-07-02 with a primary completion date of 2030-07-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This protocol describes a 20-year prospective cohort study, gathering behavioral and psychosocial information on clients who access services of the Institute of HIV Research and Innovation (IHRI) and the Thai Red Cross AIDS Research Centre through the Thai Red Cross Anonymous Clinic, the Thai Red Cross Mobile Clinics, Affiliated Health Clinics, The gender and immunity clinic and Pribta Tangerine Polyclinic. Services provided through these sites include VCT, STD screening and treatment, anal and cervical Pap smears, general health checkups, sexual health education, and sexual health communication, gender-affirmative hormone therapy (GAHT) and risk-reduction via web boards and chat rooms. Behavioral and psychosocial information will be collected using validated questionnaires and from data collection forms routinely used when providing services in different service sites of IHRI and the TRC-ARC. The information will be collected anonymously at baseline and at follow-up visits, according to type of services each client receives. Clients at the Thai Red Cross Anonymous Clinic, Thai Red Cross Mobile Health Clinics, Affiliated Health Clinics and Pribta Tangerine Polyclinic will be given an identification number. Qualitative methods, including focus group discussions (FGD) and in-depth interviews (IDI) will be conducted with clients and healthcare providers to examine the facilitators, barriers, feasibility and acceptability of service implementation.
Eligibility Criteria
Inclusion Criteria: 1. 18 years or 16 and 17 years of age with parental or guardian consent In non- or pre-SRS cases 2. Recommendation1 by counsellor based on: A) Presence of GD history B) Understanding of risks and benefits of GAHT D) Practice and readiness for gender transition E) Availability of social support F) Ability to take hormones as instructed 3. Verbal informed consent or signed informed consent on file 4. No exclusionary medical conditions 5. Approved by physician In SRS- and post-SRS cases2 1. Verbal informed consent or signed informed consent on file 2. No exclusionary medical conditions 3. Approved by physician Exclusion Criteria: None
Contact & Investigator
Siriporn Nonenoy, BNH,MPH
STUDY CHAIR
Institute of HIV Research and Innovation
Frequently Asked Questions
Who can join the NCT06741319 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06741319 currently recruiting?
Yes, NCT06741319 is actively recruiting participants. Contact the research team at nittaya.p@ihri.org for enrollment information.
Where is the NCT06741319 trial being conducted?
This trial is being conducted at Pathum Wan, Thailand.
Who is sponsoring the NCT06741319 clinical trial?
NCT06741319 is sponsored by Institute of HIV Research and Innovation Foundation, Thailand. The principal investigator is Siriporn Nonenoy, BNH,MPH at Institute of HIV Research and Innovation. The trial plans to enroll 300,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.